SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today announced that enrollment in the MOTIV pivotal trial has ...
SAN DIEGO, CA, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- REVA Medical, LLC, a leader in the development of bioresorbable vascular scaffolds (BRS) for ...
MOTIV is made from REVA's proprietary polymer, Tyrocore, which was developed specifically for scaffold performance. The novel properties of Tyrocore provide for enhanced scaffold strength in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback